Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2009

Arora N, Scognamiglio T, Lubitz CC, Moo TA, Kato MA, Zhu B, et al. Identification of borderline thyroid tumors by gene expression array analysis. Cancer. 2009;115(23):5421-31.

Snyder EL, Bailey D, Shipitsin M, Polyak K, Loda M. Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies. Lab Invest. 2009;89(8):857-66.

Robinson BD, Sica GL, Liu Y-, Rohan TE, Gertler FB, Condeelis JS, et al. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res. 2009;15(7):2433-41.

Moscat J, Diaz-Meco MT. To aggregate or not to aggregate? A new role for p62. EMBO Rep. 2009;10(8):804.

Lu DY, Nassar A, Siddiqui MT. High-grade urothelial carcinoma: comparison of SurePath liquid-based processing with cytospin processing. Diagn Cytopathol. 2009;37(1):16-20.

Das C, M Lucia S, Hansen KC, Tyler JK. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature. 2009;459(7243):113-7.

Mosunjac M, Park J, Wang W, Tadros T, Siddiqui M, Bagirov M, et al. Genital and perianal herpes simplex simulating neoplasia in patients with AIDS. AIDS Patient Care STDS. 2009;23(3):153-8.

Solomon JP, Yonemoto IT, Murray AN, Price JL, Powers ET, Balch WE, et al. The 8 and 5 kDa fragments of plasma gelsolin form amyloid fibrils by a nucleated polymerization mechanism, while the 68 kDa fragment is not amyloidogenic. Biochemistry. 2009;48(48):11370-80.

Chen C-, Tyler J. Selective sensitization of cancer cells to DNA damage by a HAT inhibitor. Cell Cycle. 2009;8(18):2867.

Nguyen T, Shepela C, Patnaik M, Jessurun J. Pulmonary nodules as an extra-intestinal manifestation of inflammatory bowel disease: a case series and review of the literature. Dig Dis Sci. 2009;54(5):1135-40.